Jetzt bei Plus500 CFDs auf die weltweit gefragtesten Basiswerte wie Aktien, Indizes oder Kryptowährungen entdecken!5 -W-
30.01.2024 11:26:08

EQS-AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: Biotest AG / Preliminary announcement on the disclosure of financial statements
Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

30.01.2024 / 11:26 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Biotest AG hereby announces that the following financial reports shall be disclosed:

Report Type: Financial report of the group (half-year/Q2)

Language: German
Date of disclosure: July 30, 2024
Address: https://www.biotest.com/de/de/investor_relations/news_und_publikationen_/publikationen/quartalsberichte.cfm

Language: English
Date of disclosure: July 30, 2024
Address: https://www.biotest.com/de/en/investor_relations/news_and_publications/publications/quarterly_reports.cfm


30.01.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Germany
Internet: www.biotest.de

 
End of News EQS News Service

1826201  30.01.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1826201&application_name=news&site_id=smarthouse

Analysen zu Biotest AG Vz.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Biotest AG Vz. 27,00 0,37% Biotest AG Vz.